Free Access
Issue
J Extra Corpor Technol
Volume 48, Number 3, September 2016
Page(s) 113 - 121
DOI https://doi.org/10.1051/ject/201648113
Published online 15 September 2016
  1. Trulock E. P., Christie J. D., Edwards L. B., et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007;26:782–95. [CrossRef] [Google Scholar]
  2. Thabut G., Mal H., Castier Y., et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg. 2003;126:469–75. [CrossRef] [Google Scholar]
  3. Orens J. B., Boehler A., de Perrot M., et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22:1183–200. [CrossRef] [Google Scholar]
  4. Sekine Y., Waddell T. K., Matte-Martyn A., et al. Risk quantification of early outcome after lung transplantation: Donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant. 2004;23:96–104. [CrossRef] [Google Scholar]
  5. Meyers B. F., Sundt T. M., Henry S., et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg. 2000;120:20–6. [CrossRef] [Google Scholar]
  6. Oto T., Rosenfeldt F., Rowland M., et al. Extracorporeal membrane oxygenation after lung transplantation: Evolving technique improves outcomes. Ann Thorac Surg. 2004;78:1230–5. [CrossRef] [Google Scholar]
  7. Ko W. J., Chen Y. S., Luh S. P., Lee Y. C., Chu S. H. Extracorporeal membrane oxygenation support for single-lung transplantation in patients with primary pulmonary hypertension. Transplant Proc. 1999;31:166–8. [CrossRef] [Google Scholar]
  8. Fischer S., Simon A. R., Welte T., et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg. 2006;131:719–23. [CrossRef] [Google Scholar]
  9. Pereszlenyi A., Lang G., Steltzer H., et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg. 2002;21:858–63. [CrossRef] [Google Scholar]
  10. Abrams D. C., Brodie D., Rosenzweig E. B., Burkart K. M., Agerstrand C. L., Bacchetta M. D. Upper-body extracorporeal membrane oxygenation as a strategy in decompensated pulmonary arterial hypertension. Pulm Circ. 2013;3:432–5. [CrossRef] [Google Scholar]
  11. Belohlavek J., Rohn V., Jansa P., et al. Veno-arterial ECMO in severe acute right ventricular failure with pulmonary obstructive hemodynamic pattern. J Invasive Cardiol. 2010;22:365–9. [Google Scholar]
  12. Alwardt C. M., Patel B. M., Lowell A., Dobberpuhl J., Riley J. B., DeValeria P. A. Regional perfusion during venoarterial extracorporeal membrane oxygenation: A case report and educational modules on the concept of dual circulations. J Extra Corpor Technol. 2013;45:187–94. [Google Scholar]
  13. Avgerinos D. V., DeBois W., Voevidko L., Salemi A. Regional variation in arterial saturation and oxygen delivery during venoarterial extracorporeal membrane oxygenation. J Extra Corpor Technol. 2013;45:183–6. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Balik M., Rulisek J., Leden P., et al. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr. 2012;124:552–6. [CrossRef] [PubMed] [Google Scholar]
  15. Gore D. C., Wolfe R. R. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery. 2006;139:686–94. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.